In this study, Ang-II could significantly stimulate cardiac hypertrophy in NRCMs by increasing the cross-sectional cell area (Fig. 1A) and level of fetal genes, including ANP and BNP (Fig. 1B, C). This evidence concerns the gene AGT and cardiac hypertrophy.